Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin
- PMID: 455329
Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin
Abstract
Golden hamsters received Adriamycin (ADR), detorubicin (DTR), AD-32, or aclacinomycin (ACM) three times weekly at doses extrapolated from optimal doses in L1210 leukemia. Minimal early lesions of the myocardium were detected by electron microscopy in ACM-treated animals. These lesions were aggravated after several weeks of treatment but remained reversible. Lesions in AD-32-treated hamsters were slightly more marked than those seen in ACM-treated animals but were much less severe than those observed in ADR- or DTR-treated animals. Similarly, light microscopy revealed pathologic changes in the skin following ADR or DTR administration. These changes were not seen in animals receiving AD-32 or ACM.
Similar articles
-
[Ultrastructural study of cardiotoxicity and skin alterations in the golden hamster after treatment with 8 different anthracyclines].C R Seances Soc Biol Fil. 1979;173(2):394-413. C R Seances Soc Biol Fil. 1979. PMID: 159762 French.
-
Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs.Biomed Pharmacother. 1984;38(7):322-8. Biomed Pharmacother. 1984. PMID: 6240996
-
Ultrastructural study of the cardiotoxicity and light-microscopic findings of the skin after treatment of golden hamsters with seven different anthracyclines.Recent Results Cancer Res. 1980;74:223-49. doi: 10.1007/978-3-642-81488-4_28. Recent Results Cancer Res. 1980. PMID: 7444141
-
Experimental studies on aclacinomycin.Drugs Exp Clin Res. 1985;11(1):9-15. Drugs Exp Clin Res. 1985. PMID: 2424701 Review.
-
Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.Drugs Exp Clin Res. 1986;12(1-3):275-82. Drugs Exp Clin Res. 1986. PMID: 3525076 Review.
Cited by
-
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.Cancer Chemother Pharmacol. 1978;1(4):259-62. doi: 10.1007/BF00257160. Cancer Chemother Pharmacol. 1978. PMID: 373923 Clinical Trial.
-
Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone.Cancer Chemother Pharmacol. 1989;25(2):135-8. doi: 10.1007/BF00692354. Cancer Chemother Pharmacol. 1989. PMID: 2598400
-
4'-O-tetrahydropyranyl adriamycin (THP-ADM)-induced modifications of murine peritoneal macrophages.Med Oncol Tumor Pharmacother. 1989;6(1):71-5. doi: 10.1007/BF02985226. Med Oncol Tumor Pharmacother. 1989. PMID: 2786120
-
Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin.Cancer Chemother Pharmacol. 1982;8(2):243-9. doi: 10.1007/BF00255491. Cancer Chemother Pharmacol. 1982. PMID: 6955072
-
Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing.Cancer Chemother Pharmacol. 2024 Aug;94(2):123-139. doi: 10.1007/s00280-024-04693-1. Epub 2024 Jul 4. Cancer Chemother Pharmacol. 2024. PMID: 38965080 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials